425 related articles for article (PubMed ID: 8878440)
1. Dermal injection of immunocytes induces psoriasis.
Wrone-Smith T; Nickoloff BJ
J Clin Invest; 1996 Oct; 98(8):1878-87. PubMed ID: 8878440
[TBL] [Abstract][Full Text] [Related]
2. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161.
Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA
Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195
[TBL] [Abstract][Full Text] [Related]
3. 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice.
Dam TN; Kang S; Nickoloff BJ; Voorhees JJ
J Invest Dermatol; 1999 Dec; 113(6):1082-9. PubMed ID: 10594756
[TBL] [Abstract][Full Text] [Related]
4. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis.
Nickoloff BJ; Wrone-Smith T
Am J Pathol; 1999 Jul; 155(1):145-58. PubMed ID: 10393847
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: human skin model of psoriasis.
Nickoloff BJ
J Investig Dermatol Symp Proc; 2000 Dec; 5(1):67-73. PubMed ID: 11147678
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.
de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK
Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors.
Gilhar A; Ullmann Y; Kerner H; Assy B; Shalaginov R; Serafimovich S; Kalish RS
J Invest Dermatol; 2002 Aug; 119(2):384-91. PubMed ID: 12190861
[TBL] [Abstract][Full Text] [Related]
8. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice.
Gilhar A; David M; Ullmann Y; Berkutski T; Kalish RS
J Invest Dermatol; 1997 Sep; 109(3):283-8. PubMed ID: 9284091
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
[TBL] [Abstract][Full Text] [Related]
10. The search for pathogenic T cells and the genetic basis of psoriasis using a severe combined immunodeficient mouse model.
Nickoloff BJ
Cutis; 2000 Feb; 65(2):110-4. PubMed ID: 10696565
[TBL] [Abstract][Full Text] [Related]
11. Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model.
Nickoloff BJ; Kunkel SL; Burdick M; Strieter RM
Am J Pathol; 1995 Mar; 146(3):580-8. PubMed ID: 7887440
[TBL] [Abstract][Full Text] [Related]
12. The role of immune system in the pathogenesis of psoriasis.
Baadsgaard O; Fisher G; Voorhees JJ; Cooper KD
J Invest Dermatol; 1990 Nov; 95(5 Suppl):32S-34S. PubMed ID: 16788627
[TBL] [Abstract][Full Text] [Related]
13. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions.
Nickoloff BJ; Mitra RS; Elder JT; Fisher GJ; Voorhees JJ
Br J Dermatol; 1989 Aug; 121(2):161-74. PubMed ID: 2476168
[TBL] [Abstract][Full Text] [Related]
14. Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there interaction between dendritic cells and keratinocytes?
Komine M; Karakawa M; Takekoshi T; Sakurai N; Minatani Y; Mitsui H; Tada Y; Saeki H; Asahina A; Tamaki K
J Invest Dermatol; 2007 Aug; 127(8):1915-22. PubMed ID: 17446902
[TBL] [Abstract][Full Text] [Related]
15. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
16. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines.
Nestle FO; Turka LA; Nickoloff BJ
J Clin Invest; 1994 Jul; 94(1):202-9. PubMed ID: 8040262
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system.
Nickoloff BJ; Bonish B; Huang BB; Porcelli SA
J Dermatol Sci; 2000 Dec; 24(3):212-25. PubMed ID: 11084303
[TBL] [Abstract][Full Text] [Related]
18. Xenotransplantation Model of Psoriasis.
Di Domizio J; Conrad C; Gilliet M
Methods Mol Biol; 2017; 1559():83-90. PubMed ID: 28063039
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A.
Gupta AK; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
Arch Dermatol Res; 1989; 281(4):219-26. PubMed ID: 2673064
[TBL] [Abstract][Full Text] [Related]
20. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes.
Paukkonen K; Naukkarinen A; Horsmanheimo M
Arch Dermatol Res; 1995; 287(2):165-70. PubMed ID: 7763088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
